Product Images Desvenlafaxine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Desvenlafaxine NDC 50090-4388 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structure - image 1
1 - image 2
This is a pharmacokinetic analysis of the impact of different intrinsic factors such as renal and hepatic impairment and population description on Desvenlafaxine. The results are shown in Figure 1 and include values for Cmax and AUC. The study involves different levels of impairment and population description such as gender and age. Not available.*
2 - image 3
3 - image 4
4 - image 5
This is a graph representing the estimated proportion of patients with relapse, with Desvenlafaxine 50 mg and Placebo as the two variables. The x-axis shows the time to relapse in days from randomization and the y-axis shows the percentage of patients with relapse. The graph shows that at around 50 days, the proportion of patients with relapse is around 40% for the Desvenlafaxine group and around 50% for the Placebo group. At 200 days, the percentage of patients with relapse for both groups is 0.*
5 - image 6
This is a graph that compares Desvenlafaxine to Placebo in terms of the percentage of patients with relapse over time in days from randomization. It shows that fewer patients experienced relapse with Desvenlafaxine compared to Placebo.*
Label Image - lbl500904388
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
